NLM Logo

specific substance maruyama MeSH Supplementary Concept Data 2024


MeSH Supplementary
specific substance maruyama
Unique ID
C031208
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C031208
Entry Term(s)
Ancer 20
Z-100
Pharm Action
Adjuvants, Immunologic
Antineoplastic Agents
Registry Number
0
Previous Indexing
*BIOLOGICAL PRODUCTS (81-9)
Heading Mapped to
*Lipids
*Mannans
Frequency
49
Note
an extract from human tubercle bacilli, so called Maruyama vaccine; immunotherapeutic anticancer agent prepared from extract of Mycobacterium tuberculosis strain of Aoyama B
Source
Microbiol Immunol 1981;25(3):305
Date of Entry
1981/08/20
Revision Date
2007/07/09
specific substance maruyama Preferred
Z-100 Narrower
Ancer 20 Narrower
page delivered in 0.003s